588730-16-9,
N-methyl-1-(4-methyl-1,2,5-oxadiazol-3-yl)methanamine,
Methyl-(4-methyl-furazan-3-ylmethyl)-amine,
3-Methylaminomethyl-4-methyl-1,2,5-oxadiazole,
METHYL[(4-METHYL-1,2,5-OXADIAZOL-3-YL)METHYL]AMINE,
methyl[(4-methyl(1,2,5-oxadiazol-3-yl))methyl]amine,
ZERO/004814,
AC1NP9CN,
SCHEMBL13849701,
CTK1G9238,
DTXSID90409442,
HMS1700B11,
ZINC4344067,
8744AB,
ANW-63038,
BBL030635,
MFCD06738812,
SBB010253,
STK785702,
AKOS000302673,
AB27939,
MCULE-9655445822,
AJ-50727,
AN-27893,
AS-30832,
BAS 10142508,
Methyl-(4-methylfurazan-3-ylmethyl)amine,
DB-072537,
RT-008816,
ST4130698,
BB 0218292,
FT-0759738,
ST24048613,
Y-2415,
730M169,
A832055,
N-methyl(4-methyl-1,2,5-oxadiazol-3-yl)methanamine,
C5H9N3O,
CID5200324,
N,4-Dimethyl-1,2,5-oxadiazole-3-methanamine,
(2,4-dimethyl-2,5-dihydro-1,2,5-oxadiazol-3-yl)methanamine,
METHYL-(4-METHYL-FURAZAN-3-YLMETHYL)-AMINE HYDROCHLORIDE,